Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Opdualag in Adolescent and Young Adult Patients Newly Diagnosed With Replication Repair Deficient High-Grade Glioma
NCT07644312Phase 2Not yet recruiting
- Sponsor
- Nationwide Children's Hospital
- Start
- Mar 2027
- Primary completion
- Mar 2033
01
Overview
A Phase 2 trial of relatlimab in glioma, diffuse intrinsic pontine glioma (DIPG), sponsored by Nationwide Children's Hospital. Planned start Mar 2027; status: not yet recruiting.
02
Drugs
relatlimab
03
Conditions
gliomadiffuse intrinsic pontine glioma (DIPG)
Beyond the preview
Go deeper on NCT07644312.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07644312.